Gestational Weight Gain: Results from the Delta Healthy Sprouts Comparative Impact Trial

Table 5

Delta Healthy Sprouts participant delivery outcomes and infant birth characteristics by treatment.

Characteristic	⁢PAT ()		⁢PATE ()
		%		%
Delivery mode					0.887
Vaginal (not induced)	18	60.0	13	54.2
Vaginal (induced)	5	16.7	5	20.8
C-section (planned)	4	13.3	2	8.3
C-section (unplanned)	3	10.0	4	16.7
Birth complications	2	6.7	2	8.7	1.000
Infant gender: female	9	30.0	14	58.3	0.036
Infant ethnicity: non-Hispanic	29	96.7	24	100.0	1.000
Infant race					1.000
African American	29	96.7	23	95.8
White	1	3.3	1	4.2
Premature (<37 weeks gestation)	5	16.7	2	8.3	0.443
Low birth weight (<2500 g at birth)	2	6.7	5	20.8	0.221
Macrosomia (>4000 g at birth)	2	6.7	2	8.3	1.000
SGA (<10th percentile)	2	6.7	5	20.8	0.221
LGA (>90th percentile)	2	6.7	3	12.5	0.646

PAT, Parents as Teachers control treatment; PATE, Parents as Teachers Enhanced experimental treatment; SGA, small for gestational age; LGA, large for gestational age.
Comparison: vaginal versus C-section.
Other than premature delivery; complications: low blood sugar, sickle cell anemia, and jaundice. 1 PATE participant response missing.
Based on conception date (calculated using online pregnancy calculator and self-reported due date).
No infant exceeded 4500 g at birth; 4 of 5 LGA infants are also classified as having macrosomia.
Based on sex specific birthweight percentiles for 2 white infants and race specific birthweight percentiles for 52 African American infants.